Verdence Capital Advisors »

Gt Biopharma shares owned by Verdence Capital Advisors

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Verdence Capital Advisors from 13F filings

Historical chart of Verdence Capital Advisors investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Verdence Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Verdence Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $10k 13k 0.79

More positions owned by Verdence Capital Advisors

Apple (AAPL)
Spdr Series Trust State Street Spd (BIL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Ishares Tr Core Us Aggbd Et (AGG)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Eafe Etf (EFA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
New York Life Investments Et Nyli Hedge Multi (QAI)

View all positions for Verdence Capital Advisors

Top funds holding Gt Biopharma

DRW Holdings
SeaCrest Wealth Management
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Verdence Capital Advisors
Parsons Capital Management
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Wolff Wiese Magana
Newbridge Financial Services Group
Farther Finance Advisors
Tower Research Capital
Spire Wealth Management

View all funds holding Gt Biopharma